UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 28, 2020
Accession Number:
0001373707-20-000008
Submission Type:
POS AM
CIK:
0001373707
Company Name:
TETRAPHASE PHARMACEUTICALS INC
File Number:
333-202613